France· FR:69135922
GEFITINIB BIOGARAN 250 mg, comprimé pelliculé
A medicinal product containing géfitinib, registered in France by BIOGARAN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- GÉFITINIB
- Manufacturer
- BIOGARAN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930154861plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)EUR 754.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Géfitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainGEFITINIB ACCORD 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- NetherlandsGefitinib Eugia 250 mg filmomhulde tablettenEugia Pharma (Malta) Limited
- FinlandGefitinib AccordAccord Healthcare B.V.
- BelgiumGefitinib Accord 250 mgAccord Healthcare
- PolandGefitinib AccordAccord Healthcare Polska Sp. z o.o.
- SwedenGefitinib Accord 250 mg Filmdragerad tablettAccord Healthcare B.V.
- United StatesGefitinibTeva Pharmaceuticals, Inc.
- IcelandGefitinib STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Gefitinib Accord
- Belgium · Gefitinib Accord, Gefitinib Sandoz
- Bulgaria · Фромпо
- Cyprus · Refetib
- Czechia · Gefitinib Accord
- Germany · Gefitinib Accord, Gefitinib Genthon
- Denmark · Gefitinib Accord, Gefitinib Stada
- Estonia · Gefitinib Auxilia, Gefitinib Norameda
- Spain · Gefitinib Efg Genthon, Gefitinib Eugia
- Finland · Gefitinib Accord, Gefitinib Stada
- United Kingdom (Northern Ireland) · Gefitinib Accord, Gefitinib Eugia (Uk)
- Greece · Gefitinib Faran, Gefitinib Genepharm
- Croatia · Gefitinib Pliva, Gefitinib Sandoz
- Hungary · Gefitinib Genepharm, Gefitinib Onkogen
- Iceland · Gefitinib Stada, Gefitinib Wh
- Italy · Gefitinib Medac
- Liechtenstein · Iressa
- Lithuania · Gefitinib Norameda
- Latvia · Gefitinib Norameda
- Malta · Gefitinib Eugia, Gefitinib Genthon
- Netherlands · Gefitinib Eugia, Gefitinib Genthon
- Norway · Gefitinib Stada, Iressa
- Poland · Gefitinib Accord, Gefitinib Genthon
- Portugal · Gefitinib Accord, Gefitinib Eugia
- Romania · Gefitinib Accord, Gefitinib Polisano
- Sweden · Gefitinib Accord, Gefitinib Stada
- Slovenia · Phrompo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cabd8514-5aef-4552-b3a3-383c83b7f9c2 GET /v1/drugs/cabd8514-5aef-4552-b3a3-383c83b7f9c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69135922",
"date_amm": "2018-08-03",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "GÉFITINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about géfitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.